PF-Atlas › Clinical Trials › NCT06477185

Characterization of Tuberculosis Associated Lung Fibrosis and Respiratory Impairment, and Prevention Using Doxycycline

Doxycycline · Phase 2

Registry ID

NCT06477185

Phase

Phase 2

Status

Recruiting

Drug / intervention

Doxycycline

Sponsor

Makerere University

Start

2024-12-04

About this trial

Doxycycline is evaluated in NCT06477185, a Phase 2 idiopathic pulmonary fibrosis study sponsored by Makerere University. Current status: Recruiting.

View NCT06477185 on ClinicalTrials.gov →

Explore related

All Doxycycline trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT06477185 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.